Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry v3.3.2 was added to the record history and the previous v3.2.0 revision was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding/operating status notice from the page.SummaryDifference0.8%

- Check43 days agoChange DetectedThe old and new screenshots show only cosmetic/layout differences with no updates to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference13%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, indicating a new release with updated revision metadata.SummaryDifference0.3%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.8%

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.